Studies on the site of action of o,p'-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p'-DDD inhibited steroidogenesis.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D003864:Depression, Chemical; D003907:Dexamethasone / Q000494:pharmacology; D003632:Dichlorodiphenyldichloroethane / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004285:Dogs; D006854:Hydrocortisone / Q000096:biosynthesis*; D007664:Ketosteroids / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009249:NADP / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology; D011278:Pregnanes / Q000378:metabolism; D011284:Pregnenolone / Q000378:metabolism; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D007664:Ketosteroids; D011278:Pregnanes; D014316:Tritium; D009249:NADP; D011284:Pregnenolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone